Tocotrienols, a form of vitamin E, could help preserve telomere length, which correlates directly to cellular ageing.

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Bats harbor viral human pathogens without getting sick. A new cell line could open doors to new therapies based on these ...

MAIA Biotechnology, Inc.’s MAIA share price has surged by 11.93%, which has investors questioning if this is right time to sell.

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at ...

This article delves into the hypothesized mechanisms of Vilon and its prospective roles in various research domains.

A briefing document (PDF) published by the FDA reviewer ahead of the adcomm has questioned the efficacy seen with the telomerase inhibitor, suggesting that the data doesn’t point to a disease ...

Panelists discuss how investigational therapies beyond Janus kinase (JAK) inhibition, including epigenetic modulation, telomerase inhibition, PI3K/AKT/mTOR pathway inhibition, immune modulation, TGF-β ...

Smith, Ph.D. and Ramiro Guerrero, JD, LL.M., purchased common stock and warrants in the Company’s private placement offering ...

Understanding genetic drivers of insulin resistance is crucial for addressing metabolic disorders. Here, the authors show associations involving GCKR, MLXIPL, APOA5, and APOC1, highlighting ...

Toxicities limit combination of PARP inhibitors (PARPi) and chemotherapy in patients with germline BRCA1 and BRCA2 pathogenic variant (gBRCAm) breast cancer. Here, the authors report a preclinical ...